173 related articles for article (PubMed ID: 36840393)
21. A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea.
Kang DY; Yun J; Lee SY; Koh YI; Sim DW; Kim S; Nam YH; Park JW; Kim SH; Ye YM; Park HK; Kim MH; Jee YK; Jung JW; Yang MS; Kim SH; Lee JK; Kim CW; Hur GY; Kim MY; Park SJ; Kwon YE; Choi JH; Kim JH; Kim SH; La HO; Kang MG; Park CS; Lee SM; Jeong YY; Kim HK; Jin HJ; Jeong JW; Lee J; Lee YW; Lee SE; Kim MS; Kang HR;
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):929-936.e7. PubMed ID: 32961314
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic Effects of Mesenchymal Stem Cells on a Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Model.
Park SY; Oh IY; Kim JH; Kim HJ; Seo B; Kwon OY; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
J Korean Med Sci; 2020 Apr; 35(15):e130. PubMed ID: 32301297
[TBL] [Abstract][Full Text] [Related]
23. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.
Wolf R; Matz H; Marcos B; Orion E
Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547
[TBL] [Abstract][Full Text] [Related]
24. TNF-α induced extracellular release of keratinocyte high-mobility group box 1 in Stevens-Johnson syndrome/toxic epidermal necrolysis: Biomarker and putative mechanism of pathogenesis.
Nwikue G; Olsson-Brown A; Aboheimed N; Yip V; Jolly C; Luchian A; Ressel L; Sharma A; Bergfeld W; Ahmed S; Dickinson A; Pirmohamed M; Carr DF
J Dermatol; 2023 Sep; 50(9):1129-1139. PubMed ID: 37269158
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a lymphocyte transformation test and cytokine detection assay to identify phenytoin and carbamazepine provoked DRESS or SJS/TEN in epilepsy patients.
Kumkamthornkul P; Udnaen S; Tansit T; Tuchinda P; Srinoulprasert Y
Int Immunopharmacol; 2018 Oct; 63():204-210. PubMed ID: 30103195
[TBL] [Abstract][Full Text] [Related]
26. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Abulatan IT; Ben-David SG; Morales-Colon LA; Beason E; Fakoya AO
Cureus; 2023 Nov; 15(11):e48728. PubMed ID: 38094551
[TBL] [Abstract][Full Text] [Related]
27. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T; French LE
Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721
[TBL] [Abstract][Full Text] [Related]
28. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
29. [Severe cutaneous drug reactions in children].
Mockenhaupt M
Hautarzt; 2017 Oct; 68(10):803-814. PubMed ID: 28932875
[TBL] [Abstract][Full Text] [Related]
30. TNF-α‒Mediated Keratinocyte Expression and Release of Matrix Metalloproteinase 9: Putative Mechanism of Pathogenesis in Stevens‒Johnson Syndrome/Toxic Epidermal Necrolysis.
Olsson-Brown A; Yip V; Ogiji ED; Jolly C; Ressel L; Sharma A; Bergfeld W; Liu X; Khirwadkar N; Bellon T; Dickinson A; Ahmed S; Langton A; Watson R; Pirmohamed M; Carr DF
J Invest Dermatol; 2023 Jun; 143(6):1023-1030.e7. PubMed ID: 36581093
[TBL] [Abstract][Full Text] [Related]
31. Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020.
Tee CT; Abdullah NH; Kristummoonthy P; Lee CS
Med J Malaysia; 2022 Jul; 77(4):409-414. PubMed ID: 35902928
[TBL] [Abstract][Full Text] [Related]
32. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
33. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
Kim HK; Kim DY; Bae EK; Kim DW
J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and prognostic factors of severe cutaneous adverse drug reactions: A single-center retrospective study of 209 cases in China.
Deng M; Su Y; Wu R; Li S; Tang G; Kuang Q; Luo X; Zhu Y; Shen W
Int Immunopharmacol; 2023 Jan; 114():109530. PubMed ID: 36508915
[TBL] [Abstract][Full Text] [Related]
35. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population.
Tassaneeyakul W; Prabmeechai N; Sukasem C; Kongpan T; Konyoung P; Chumworathayi P; Tiamkao S; Khunarkornsiri U; Kulkantrakorn K; Saksit N; Nakkam N; Satapornpong P; Vannaprasaht S; Sangviroon A; Mahasirimongkol S; Wichukchinda N; Rerkpattanapipat T; Tassaneeyakul W
Pharmacogenet Genomics; 2016 May; 26(5):225-34. PubMed ID: 26928377
[TBL] [Abstract][Full Text] [Related]
36. Searching for the Culprit Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis from a Nationwide Claim Database in Korea.
Yang MS; Lee JY; Kim J; Kim GW; Kim BK; Kim JY; Park HW; Cho SH; Min KU; Kang HR
J Allergy Clin Immunol Pract; 2020 Feb; 8(2):690-695.e2. PubMed ID: 31614216
[TBL] [Abstract][Full Text] [Related]
37. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.
Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A
Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531
[TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
39. [Severe skin reactions due to new medications].
Mockenhaupt M; Paulmann M
Hautarzt; 2018 Apr; 69(4):278-289. PubMed ID: 29568997
[TBL] [Abstract][Full Text] [Related]
40. [Recent progress in research of pathogeneses of Stevens-Johnson syndrome and toxic epidermal necrolysis].
Gao TT; Long Q
Zhonghua Yan Ke Za Zhi; 2016 Sep; 52(9):708-13. PubMed ID: 27647252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
